跳至主要内容
临床试验/CTRI/2026/03/105425
CTRI/2026/03/105425尚未招募Unknown

A Clinical Study to Evaluate the effectiveness of Meso Odeon Face & Body Scrub-Turmeric & Yogurt for brightening

Meso Pvt Ltd1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2026年3月14日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
36
试验地点
1

研究概览

简要总结

A single blind one arm study.

Each participant entering the trial will be assigned to a regimen of investigational product with the below assessments.

- Skin Hydration with Corneometer (T0, 24hrs, T7days,T14days)

- TEWL for moisture barrier (T0, 24hrs, T7days,T14days)

- Blackheads by Visio (T0, T7days,T14days)

- Dark Spots by Visio(T0, T7days,T14days)

- Skin Color by Colorimeter (T0, T7days,T14days)

- Skin Melanin by Mexameter (T0, T7days,T14days)

- Dermat evaluation on a 5 point ordinal scale would be used for the even skin tone (T0, T7days,T14days)

- Dermat evaluation on a 5 point ordinal scale would be used for the skin radiance (T0, T7days,T14days)

- Dermat evaluation on a 5 point ordinal scale would be used for the skin tan (T0, T7days,T14days)

- HD Imaging with DSLR or Visioscan (T0 and T14)

Assessment Time: T0min, T+24hrs, T+7days, T+14 days

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)

入选标准

  • Gender: Male and Female with age 18-
  • Subjects with tanned and dull skin.
  • Subjects willing to give written informed consent 4)Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
  • Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

排除标准

  • 1.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 2.Have open sores or open lesions in the treatment area(s).
  • 3.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
  • 4.Have participated in any interventional clinical trial in the previous 90 days.
  • 5.Have a known sensitivity to any of the constituents of the test product including sensitivities to (mention some of active ingredient’s name) 6.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
  • 7.Have not skin related issues.

研究者

发起方
Meso Pvt Ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Robin Chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验